Is expensive always better? Comparison of two induction agents for term rupture of membranes

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 3, 2008, Pages 290-293

  Parisaei, M ^a   Erskine, K J ^b  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Induction; Misoprostol; Prelabour rupture of membranes; Prostin

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; MISOPROSTOL; OXYTOCIN; PARACETAMOL; PENICILLIN G; PROSTAGLANDIN E2;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; LABOR INDUCTION; MEMBRANE RUPTURE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, SUBLINGUAL; ADULT; COST SAVINGS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXTRAEMBRYONIC MEMBRANES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LABOR, INDUCED; LONDON; MISOPROSTOL; OXYTOCICS; PATIENT SATISFACTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; REFERENCE VALUES; RISK ASSESSMENT; SINGLE-BLIND METHOD; TERM BIRTH;

EID: 45749149573     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802042951     Document Type: Article

References (21)

1. Alfirevic Z. 2001. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2:CD001338.
2. Aronsson A, Bygdeman M, Gemzell-Danielsson K. 2004. Effects of misoprostol on uterine contractility following different routes of administration. Human Reproduction 19:81-84.
3. British National Formulary. 2005. British Medical Association and Royal Pharmaceutical Society of Great Britain, London.
4. Caliskan E, Bodur H, Ozeren S, Corakci A, Ozkan S, Yucesoy I. 2005. Misoprostol 50 mcg sublingually versus vaginally for labour induction at term. Gynecologic and Obstetric Investigation 59:155-161.
5. Dede FS, Haberal A, Dede H, Sivaslioglu A, Arslanpence I. 2004. Misoprostol for cervical ripening and labor induction in pregnancies with oligohydramnios. Gynecologic and Obstetric Investigation 57:139-143.
6. Farah LA, Sanchez-Ramos L, Rosa C, Del Valle GO, Gaudier FL, Delke I et al. 1997. Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction. American Journal of Obstetrics and Gynecology 177:364-371.
7. Gregson S, Waterstone M, Norman I, Murrells T. 2005. A randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term. International Journal of Obstetrics and Gynaecology 112:438-444.
8. Hoffmann RA, Anthony J, Fawcus S. 2001. Oral Misoprostol vs. placebo in the management of prelabour rupture of membranes at term. International Journal of Gynaecology and Obstetrics 72:215-221.
9. Imseis HM, Trout WC, Gibbe SG. 1999. The microbiological effect of digital cervical examination. American Journal of Obstetrics and Gynecology 180:578-580.
10. Lo JY, Alexander JM, McIntire DM, Jeveno KJ. 2003. Ruptured membranes at term: randomised, double blind trial of oral misoprostol for labour induction. Obstetrics and Gynecology 10:685-689.
11. Mckenna DS, Ester JB, Proffitt M, Waddell KR. 2004. Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomised trial. Obstetrics and Gynecology 104:579-584.
12. Muzonzini G, Hofmeyr G. 2004. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 4:CD004221.
13. Ngai SW, Chan YM, Lam SW, Lao TT. 2000. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. International Journal of Obstetrics and Gynaecology 107:222-227.
14. Paungmora N, Herabutya Y, O-Prasertsawat P, Punyavachira P. 2004. Comparison of oral and vaginal misoprostol for induction of labour at term: a randomised controlled trial. Journal of Obstetrics and Gynaecology Research 30:358-362.
15. Ramsey PS, Meyer L, Walkes BA, Harris D, Ogburn PL Jr, Heise RH et al. 2005. Cardiotocographic abnormalities associated with dinoprostone and misoprostol cervical ripening. Obstetrics and Gynecology 105:85-90.
16. Rozenberg P, Chevret S, Senat MV, Bretelle F, Paule Bonnal A, Ville Y. 2004. A randomized trial that compared intravaginal misoprostol and dinoprostone vaginal insert in pregnancies at high risk of fetal distress. American Journal of Obstetrics and Gynecology 191:247-253.
17. Schaff EA, Dicenzo R, Fielding SL. 2005. Comparison of misoprostol plasma concentration following buccal and sublingual administration. Contraception 71:22-25.
18. Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE et al. 1997. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. American Journal of Obstetrics and Gynecology 177:1024-1029.
19. Shetty A, Stewart K, Stewart G, Rice P, Danielian P, Templeton A. 2002. Active management of term prelabour rupture of membranes with oral misoprostol. International Journal of Obstetrics and Gynaecology 109:1354-1358.
20. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. 2002. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 17:332-336.
21. Weeks AD, Fiala C, Safar P. 2005. Misoprostol and the debate over off-label drug use. International Journal of Obstetrics and Gynaecology 112:269-272.